Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10008
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pekel, Gökhan | - |
dc.contributor.author | Acer, S. | - |
dc.contributor.author | Çetin, E.N. | - |
dc.contributor.author | Yağcı, R. | - |
dc.contributor.author | Kaşıkçı, A. | - |
dc.contributor.author | Çevik, A. | - |
dc.date.accessioned | 2019-08-16T13:09:12Z | |
dc.date.available | 2019-08-16T13:09:12Z | |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0165-5701 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10008 | - |
dc.identifier.uri | https://doi.org/10.1007/s10792-014-9991-z | - |
dc.description.abstract | The purpose of the present study was to examine the effects of intravitreal ranibizumab on ocular pulse amplitude (OPA) and retinal vessel caliber (RVC) in wet age-related macular degeneration (AMD). Thirty-two eyes of 32 wet AMD patients were included in this case series. Three consecutive monthly injections of ranibizumab were performed. The OPA was measured with the Pascal dynamic contour tonometer. RVC measurements were taken with spectral-domain optical coherence tomography. Pre-injection mean OPA value was 2.55 ± 0.76 mmHg and post-injections mean OPA value was 2.79 ± 0.88 mmHg at the last visit (p = 0.10). Pre-injection mean arteriole and venule RVC were 96.7 ± 9.4 and 125.9 ± 8.4 µm; while post-injections arteriole and venule RVC were 96.0 ± 8.7 and 125.6 ± 8.9 µm, respectively (p > 0.05). OPA and RVC are unchanged after triple intravitreal ranibizumab injections, indicating that this treatment does not significantly alter gross retina-choroidal vasculature and hemodynamics. © 2014, Springer Science+Business Media Dordrecht. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Kluwer Academic Publishers | en_US |
dc.relation.ispartof | International Ophthalmology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Age-related macular degeneration | en_US |
dc.subject | Intraocular pressure | en_US |
dc.subject | Intravitreal injection | en_US |
dc.subject | Ocular pulse amplitude | en_US |
dc.subject | Ranibizumab | en_US |
dc.subject | Retinal vessel caliber | en_US |
dc.subject | ranibizumab | en_US |
dc.subject | angiogenesis inhibitor | en_US |
dc.subject | adult | en_US |
dc.subject | age related macular degeneration | en_US |
dc.subject | aged | en_US |
dc.subject | arteriole | en_US |
dc.subject | Article | en_US |
dc.subject | choroid vascularization | en_US |
dc.subject | clinical article | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug efficacy | en_US |
dc.subject | female | en_US |
dc.subject | human | en_US |
dc.subject | male | en_US |
dc.subject | non contact tonometer | en_US |
dc.subject | ocular pulse amplitude | en_US |
dc.subject | prospective study | en_US |
dc.subject | retina blood flow | en_US |
dc.subject | retina blood vessel | en_US |
dc.subject | retinal vessel caliber | en_US |
dc.subject | spectral domain optical coherence tomography | en_US |
dc.subject | treatment duration | en_US |
dc.subject | venule | en_US |
dc.subject | visual acuity | en_US |
dc.subject | visual system parameters | en_US |
dc.subject | wet macular degeneration | en_US |
dc.subject | blood flow | en_US |
dc.subject | drug effects | en_US |
dc.subject | fluorescence angiography | en_US |
dc.subject | intraocular pressure | en_US |
dc.subject | intravitreal drug administration | en_US |
dc.subject | middle aged | en_US |
dc.subject | oculoplethysmography | en_US |
dc.subject | optical coherence tomography | en_US |
dc.subject | pathology | en_US |
dc.subject | pathophysiology | en_US |
dc.subject | physiology | en_US |
dc.subject | pulse rate | en_US |
dc.subject | very elderly | en_US |
dc.subject | Aged | en_US |
dc.subject | Aged, 80 and over | en_US |
dc.subject | Angiogenesis Inhibitors | en_US |
dc.subject | Female | en_US |
dc.subject | Fluorescein Angiography | en_US |
dc.subject | Humans | en_US |
dc.subject | Intraocular Pressure | en_US |
dc.subject | Intravitreal Injections | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Pulse | en_US |
dc.subject | Regional Blood Flow | en_US |
dc.subject | Retinal Vessels | en_US |
dc.subject | Tomography, Optical Coherence | en_US |
dc.subject | Tonometry, Ocular | en_US |
dc.subject | Wet Macular Degeneration | en_US |
dc.title | Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 35 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 657 | |
dc.identifier.startpage | 657 | en_US |
dc.identifier.endpage | 662 | en_US |
dc.identifier.doi | 10.1007/s10792-014-9991-z | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 25186317 | en_US |
dc.identifier.scopus | 2-s2.0-84940385971 | en_US |
dc.identifier.wos | WOS:000360386500011 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
7
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
6
checked on Nov 21, 2024
Page view(s)
40
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.